Advertisement

Organisation › Details
Zetta Genomics (Group)
University of Cambridge technology spin-out Zetta Genomics announces that is has raised £2.5 million in new seed funding. The successful round secures leading global Venture Capital (VC) investment in the company’s XetaBase platform – a transformational genomic data management technology that powers the discovery and delivery of precision medicine at scale. Built on the open-source OpenCB platform, co-developed by Zetta Genomics founder, Ignacio Medina, XetaBase allows researchers and clinicians to securely store, easily access and dynamically interrogate vast and increasing volumes of genomic data – on demand. The technology brings genome-enabled discovery, healthcare analytics and population research into the lab – and prognostics, diagnostics and therapeutics into the clinic. Market and precision medicine opportunities have helped Zetta Genomics to create an extensive, growing and valuable partnership network with organisations such as Fujitsu, Future Perfect Healthcare, Genomics England, Microsoft, the NHS and the University of Cambridge. VC-backed funding will focus on growth, enhancing the company’s partnership network while it expands from the UK to open both Spanish and US offices. Investment will also focus on talent, with a five-fold increase in headcount to secure additional software, development and commercialisation expertise. *
![]() |
Start | 2018-07-20 established (s-off) |
Predecessor | University of Cambridge | |
![]() |
Industry | XetaBase platform (genomic data management technology) |
Industry 2 | data management and workflow software (bioinformatics) | |
![]() |
Person | Spooner, William H. (Will) (Zetta Genomics 202005– CEO + Co-Founder formerly Eagle Genomics) |
Person 2 | Medina Castello, Ignacio (Nacho) (Zetta Genomics 202402 CEO + Founder before CTO + CEO) | |
![]() |
Region | Cambridge, Cambridgeshire |
Country | United Kingdom (GB) | |
Street | 61 Regent Street Ravenscroft House, Suite 1 | |
City | CB2 1AB Cambridge, Cambridgeshire | |
Address record changed: 2024-02-10 | ||
Basic data | Employees | B: 11 to 50 (2023-04-18) |
* Document for »About Section«: Zetta Genomics Ltd.. (2/1/22). "Press Release: Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. | ||
Record changed: 2024-02-10 |
Advertisement

More documents for Zetta Genomics (Group)
- [1] Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million"....
- [2] Zetta Genomics Ltd.. (7/5/23). "Press Release: Zetta Genomics Appoints First Chief Revenue Officer"....
- [3] Zetta Genomics Ltd.. (4/18/23). "Press Release: Zetta Genomics Secures £1.9 Million in Second Round Seed Funding to Configure for Scale, Delivery and Innovation"....
- [4] Zetta Genomics Ltd.. (2/1/22). "Press Release: Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top